Introduction
Non-invasive measures of atherosclerosis are useful in cardiovascular risk prediction, especially in persons classified as intermediate risk based on risk scoring algorithms like the Framingham Risk Score. 1 -4 As atherosclerosis is a systemic process, with a substantial number of persons afflicted with disease in more than one vascular bed, risk prediction would benefit from targeting multiple components of cardiovascular disease (CVD) simultaneously. 5, 6 To date, most studies focused on one component of CVD, such as coronary heart disease (CHD) or stroke, in relation to oneor a limited number-of measures of atherosclerosis. In light of the general aspect of CVD, it is useful to relate various noninvasive measures of atherosclerosis to different components of CVD simultaneously. One current non-invasive measure of atherosclerosis is assessment of the amount of arterial calcification with computed tomography (CT). An advantage of this modality is that it can measure atherosclerosis simultaneously in multiple vascular beds. Until now, research primarily focused on measurement of coronary artery calcification (CAC). Coronary artery calcification has been established as a strong and independent risk factor for CHD and appears to improve CHD risk prediction beyond traditional risk factors by means of enhancement of the C-statistic. 7 -10 However, currently only one prospective study investigated CAC in relation to stroke, 11 while the predictive value of CAC in cerebrovascular risk prediction remains unclear.
Recently, interest in arterial calcification has been extended to other parts of the vascular tree. Two studies on thoracic aorta calcification (TAC) found that TAC had a less strong relation with CHD 12 and CVD 12,13 compared with CAC. Furthermore, TAC did not improve risk prediction over coronary calcium. 12 However, cerebrovascular disease was not examined as a separate outcome. Prospective CT studies on the association of carotid calcification and risk of cardiovascular events are still lacking. Therefore, within the prospective Rotterdam Study, we examined the association of coronary artery, aortic arch, and carotid artery calcification, assessed by CT, with the risk of CHD and cerebrovascular events. Additionally, we investigated the incremental value of calcification in these vascular beds over the Framingham risk factors.
Methods Study population
This study is embedded in the Rotterdam Study, a population-based cohort study that started in 1990. All inhabitants aged 55 years and older, living in a suburb of Rotterdam were invited and 7983 agreed to participate (78%). This group is referred to as Rotterdam Study cohort I (RS-I). In 2000, a second study cohort was introduced (RS-II) comprising 3011 persons.
14 From September 2003 until February 2006, participants completing a centre visit (visit 4 for RS-I and visit 2 for RS-II) were invited to undergo an multi-detector computed tomography (MDCT) scan. Overall 2524 participants (79%) were scanned. We excluded 328 persons with prevalent CVD at baseline, defined as percutaneous coronary intervention, coronary artery bypass grafting, recognized myocardial infarction (MI), or stroke. A further 43 participants were lost to follow-up providing 2153 persons for analyses. Due to severe artefacts in image acquisition, respectively, 19, 4, and 3 persons did not have a valid coronary, aortic arch, or carotid calcium score. Hence, the study population available for analyses for these measures were 2134, 2149, and 2150, respectively. The median duration between the study centre visit and the MDCT scan was 117 days. At the time of study inclusion, coronary calcium was not considered an indicator for treatment in the Netherlands. Nevertheless, participants in the highest 10% of the CAC score distribution for men and the highest 5% for women (with distributions based on our previous coronary calcium study 10 ) were informed about their score and advised to visit their physician. This study was approved by the Medical Ethics Committee of the Erasmus Medical Center, Rotterdam, the Netherlands. All participants gave written informed consent.
Scan protocol and analysis of calcification
Methods have been described in detail previously. 15 In short, persons were scanned with a 16-slice (n ¼ 636; 30%) or 64-slice (n ¼ 1,517; 70%) MDCT scanner (SOMATOM Sensation 16 or 64, Siemens, Forcheim, Germany). Two scans were performed. The cardiac scan reached from the apex of the heart to the tracheal bifurcation. The second scan reached from the aortic arch to the intracranial circulation (1 cm above the sella turcica). The aortic arch comprised the origin of the aortic arch (defined as the image in which the ascending and descending aorta merge into the inner curvature of the aortic arch) to the first 1 cm of the common carotid arteries, the vertebral arteries, and the subclavian arteries beyond the origin of the vertebral arteries. The carotid arteries comprised both right and left carotid artery within 3 cm proximal and distal of the bifurcation. Atherosclerotic calcification was identified based on a threshold of 130 Hounsfield Units (HU), using dedicated software (Syngo Calcium Scoring, Siemens, Forcheim, Germany). Calcification was quantified by using the Agatston score. 16 The total score per vascular bed was calculated by adding the scores of all lesions in that bed. The estimated radiation dose was up to 2.1 millisievert (mSv) for the cardiac scan and 2.8 ms for the extracardiac scan. In the minority of persons with a heart rhythm disorder, cardiac scans required somewhat higher dosages (up to 4.1 mSv). Inter-and intra-observer variability for scores of all three vascular beds was excellent (intra-class correlation coefficients ranging from 0.96 for TAC to .0.99 for CAC).
Covariables
Data on medical history, medication use, and smoking behaviour were collected using a computerized questionnaire. Established cardiovascular risk factors were measured during a visit to the research centre.
10
Diabetes was diagnosed based on a fasting plasma glucose level ≥7.0 mmol/L and/or use of anti-diabetic medication. Information on atrial fibrillation at the time of the CT scan was collected at baseline and during follow-up. 10 
Clinical outcomes
Information on cardiovascular endpoints were obtained from general practitioners and from letters and discharge reports from medical specialists. 10 Events were classified by experienced physicians according to the International Classification of Diseases, 10th edition (ICD-10).
As an outcome, we used CHD (MI and CHD mortality; ICD-10 codes: I21, I 46, I50, R96) and cerebrovascular events (TIA and ischaemic stroke; ICD-10 codes: G45, I63). If a non-fatal event occurred within 28 days of death, mortality was attributed to that event. Participants were followed for a median time (inter-quartile range) of 3.5 (2.5 -4.3) years.
Statistical analysis
Association of arterial calcification with coronary heart disease and cerebrovascular events Total cholesterol, mmol/dL 5.6 + 0.9 5.7 + 0. All three measures of calcification were categorized in the same manner. Although there are established categories for absolute coronary calcification scores, no such categories exist for aortic arch or carotid calcification scores. As about one-third of men and women of our population had a carotid calcium score of zero, we utilized tertiles. As arterial calcification scores are higher in men, gender-specific tertiles were utilized.
Additional value of calcium scores in coronary heart disease and cerebrovascular risk prediction To examine the discriminative ability of the models, we calculated the bootstrap corrected C-statistic using 150 repetitions for both models. The bootstrap method was used to correct for over-optimism of the fitted model. 19 Next, reclassification percentages were computed to study the incremental ability of calcification measures to classify subjects in 5-year risk categories of low (,5%), intermediate ( Covariables were missing in less than 3% of persons. We used single imputation by the Expectation Maximization method. All analyses were performed using SPSS 15.0 for Windows (SPSS, Inc, Chicago, Illinois) and R version 2.8.1 (R Foundation for Statistical Computing, Vienna, Austria).
Results
Baseline characteristics of the total population and within genderspecific tertiles are shown in Table 1 . During the median follow-up time of 3.5 (2.5 -4.3) years, 58 persons had a first CHD event (42 MI and 16 CHD mortality), while 52 persons had a first cerebrovascular event (26 TIA; 26 ischaemic stroke of which 2 were fatal). Table 2 displays the hazard ratios (95% CI) for the risk of CHD per tertile of calcification. Compared with persons within the lowest tertile, participants in the second and third tertiles of coronary calcification had a, respectively, 2.1 (0.7 -5.9) and 5.3-fold (2.0 -13.8) higher risk of CHD, independent of the Framingham risk factors (Model 2). Corresponding hazard ratios were: 1.4 (0.6 -3.2) and 2.5 (1.1 -5.6) for aortic arch calcification and 3.0 (1.1 -8.0) and 4.6 (1.7 -11.9) for carotid artery calcification. Table 3 displays the hazard ratios for cerebrovascular event risk per tertile of calcification in the coronary arteries, aortic arch, and carotid arteries. In contrast to our findings regarding CHD, no clear associations were found between the three measures of calcification and risk of cerebrovascular events. Carotid artery calcification seemed to be related to cerebrovascular event risk (HRs around 1.4), although clearly less strong than its relation to CHD. However, this association was not significant. No clear, significant associations were found between coronary and aortic arch calcification and cerebrovascular events. In CHD risk prediction, addition of all three calcium measures significantly improved model performance. The likelihood Chi-square of the Framingham refitted model was 38.0 and improved to 54.8 (P , 0.001) by addition of CAC, to 45.1 (P , 0.01) by addition of aortic arch calcium, and to 51. Categories of estimated 5-year CHD risk based on the Framingham risk model before and after adding coronary, aortic arch, and carotid calcium are presented in Tables 4-6 . Because arterial calcification measures did not improve cerebrovascular event risk prediction, reclassification tables were only constructed for CHD risk. The largest proportions of reclassified persons were seen in the intermediate Framingham risk group. Addition of coronary calcium reclassified 56% of persons, 36% moved to low risk while 20% moved to high risk. Addition of coronary calcium led to a net gain in reclassification of 18% in persons with an event and a net decline in reclassification of 3% in persons without event, resulting in an NRI of 1823 ¼ 15% (P , 0.01). Aortic arch calcium reclassified 32% (22% to low and 10% to high risk). The net gain in reclassification for events was 10%, and the net decline for non-events was 2%, resulting in an NRI of 1022 ¼ 8% (P ¼ 0.01). Carotid calcium reclassified 51% of persons, of whom 34% to low and 17% to high risk. The corresponding NRI was 1122 ¼ 9% (P ¼ 0.02). In most intermediate Framingham risk categories, point estimates of the observed risks agreed with the corresponding categories of predicted risk, indicating good calibration.
Discussion
In this large, prospective, population-based study, calcification of the coronary arteries, aortic arch, and carotid arteries were associated with a substantially increased risk of CHD, independent of the (7) 104 (5) NRI: 1022 ¼ 8%; P ¼ 0.01 (net gain in reclassification for events of 10% and a net decline for non-events of 2%). CI, confidence interval; NRI, net reclassification improvement.
Framingham risk factors. Furthermore, all three measures of calcification improved risk prediction of CHD beyond Framingham risk factors. In contrast, there was no significant association between calcium in any of the three vascular beds with cerebrovascular events and none of the measures of calcification improved cerebrovascular risk prediction.
Pathophysiological considerations
We found a strong and graded association of coronary, aortic arch, and carotid calcification with the risk of CHD but not with the risk of cerebrovascular events. This discrepancy may be partially explained as atherosclerosis is the main underlying mechanism of CHD, while cerebrovascular events are related to a broader array of causes. 22 Although atherosclerosis is considered an important cause of ischaemic stroke in older persons, a substantial proportion of strokes are based on other mechanisms, such as embolisms resulting from cardiac arrhythmias and/or valvular disease or hypertension giving rise to small vessel disease. 23 Another important issue is that we measured arterial calcification. While arterial calcification is an accepted measure of atherosclerotic burden, 3 its pathophysiological relation to the development of cardiovascular events is still not elucidated.
Previous studies on arterial calcification and coronary heart disease risk
Coronary artery calcification is an established, strong, and independent risk factor for CHD and has been shown to improve CHD risk prediction beyond traditional risk factors by means of enhancement of the C-statistic. 7 -10 The only prospective study on CAC examining reclassification percentages used a 5-year CHD risk model based on 209 CHD events (of which 122 hard events), among almost 6000 asymptomatic persons and found reclassification percentages to be most substantial in the intermediate risk group. In this group, 55% was reclassified: 16% to high risk and 39% to low risk. The NRI was 0.55 (P , 0.001). 24 Two recent studies in older persons free of CVD found that thoracic aorta calcium had a less strong relation with CHD and CVD compared with coronary calcium 12, 13 and did not significantly improve CHD and CVD risk prediction over Framingham risk factors or coronary calcium, as judged by change in C-statistic. 12 To our knowledge, no previous studies evaluated the relation between carotid artery calcification and risk of CHD.
Previous studies on arterial calcification and cerebrovascular risk free of CVD for a median period of 3.9 years and did not find an association of CAC with future stroke (hazard ratio (95% CI): 1.1 (0.8-1.4) per standard deviation increase of log(calcium + 1). 11 In contrast to the negative results of the current prospective study and MESA, a previous cross-sectional study within the Rotterdam Calcification Study cohort found a graded relation of CAC with history of stroke (HR (95% CI) up to 3.0 (1.3 -6.8)) for CAC .500 compared with a CAC score of 0 -100). 25 However, CAC measurement was performed on average 8.8 years after the stroke. During this period, arterial calcification may progress faster in persons with a history of stroke compared with persons without a stroke, due to mutual cardiovascular risk factors. This may lead to an overestimation of the observed association. One small prospective study investigated the association between aortic calcification, as assessed by CT, and risk of cerebrovascular events. The study comprised 455 hypertensive patients of whom 27 persons developed a TIA or stroke during 3-year follow-up. Severe calcification (defined by thickness and extension) of the descending, but not of the ascending aorta, was independently related to ischaemic cerebrovascular events. 26 To date, no prospective studies investigated the association of carotid calcification and future cerebrovascular risk.
Strengths and limitations
Our study comprised a large cohort with almost complete follow-up in which standardized measurements were performed. However, some limitations should be addressed. First, according to our study protocol, participants with a very high calcium score were informed of their score. Thus, awareness of a high calcium score may have led to lifestyle changes, initiation of medication to reduce cardiovascular risk or even an increased rate of revascularisations. Because we only used hard CHD events as an outcome, we do not expect that this information influenced our results significantly. Second, for the assessment of calcification, we used two types of MDCT scanners (16-slice and 64-slice). However, when analyses were repeated adjusting for scanner type, our results did not change substantially (data not shown). Third, in the risk prediction analyses, we fitted a model based on Framingham risk factors instead of applying the Framingham risk function. This potentially let to over-fitting, which could lead to an underestimation of the additional CAC value. However, C-statistics were corrected using bootstrapping for over-fitting. Finally, our study was performed in older persons. The predictive power of traditional cardiovascular risk factors decreases with age, while arterial calcification might improve risk stratification particularly at older age. Thus, our results may not be generalizable to younger populations.
Screening implications
In accordance with prior research, coronary calcium scoring presents as clinically useful in risk prediction of asymptomatic persons at intermediate CHD risk. Additional screening by scoring of aortic calcium did not have extra value, while additional carotid calcium measurement had a small incremental value beyond coronary calcium scoring. However, arterial calcium scores may not be clinically useful in cerebrovascular risk prediction. Although atherosclerosis is considered a generalized process, our results suggest that it is more accurate to use risk prediction algorithms for CHD and cerebrovascular disease separately than using one risk prediction algorithm to assess the risk of major CVD events.
Conclusions
Calcification of the coronary arteries, aortic arch, and carotid arteries was associated with a substantially increased risk of CHD. Moreover, all three measures of calcification significantly improved risk prediction of CHD beyond Framingham risk factors. In contrast, there was no significant association between calcium in any of the three vascular beds with cerebrovascular events and none of the measures of calcification improved cerebrovascular risk prediction.
